
Brazil's New UDI Maze: Pure Global on Dodging Hidden Data Traps in ANVISA's System.
LATAM MedTech Insights · Ran Chen
March 11, 20262m 8s
Audio is streamed directly from the publisher (episodes.captivate.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This week, we dive into a major regulatory shift in Brazil that just went live on March 1st, 2026. ANVISA's new Normative Instruction N°426/2026 activates the national UDI (Unique Device Identification) database, requiring manufacturers to submit detailed product data before entering the market. This episode breaks down the new requirements, the critical phased deadlines for different device classes, and the strategic implications for MedTech companies aiming to succeed in Latin America's largest market.
We explore the hidden complexities, such as the absolute need for data equivalence between your ANVISA registration and your UDI submission. Consider the case of a cardiac stent manufacturer whose multi-million dollar product launch is completely stalled because of a single data mismatch in the new system. This highlights how a small administrative detail can become a major commercial barrier.
Key Questions for This Episode:
- Brazil's new UDI system just went live; are you prepared for the aggressive, risk-based deadlines?
- What are the most common data mismatches that can block your market access?
- Should you manage complex UDI submissions in-house or delegate them to a local Brazilian partner?
- How does ANVISA's new database compare to the UDI systems in the US and Europe?
- What is the single most critical step to take before submitting your first UDI record to ANVISA?
- Are your current data management systems robust enough for this new era of traceability?
- How can you leverage your Brazil Registration Holder to streamline this new compliance burden?
At Pure Global, we specialize in turning these regulatory challenges into market opportunities. With our deep local expertise in Brazil and advanced AI-driven data tools, we provide end-to-end regulatory consulting to ensure your market access is seamless and compliant. We act as your local representative, manage technical dossier submissions, and navigate complex requirements like the new UDI system. To streamline your entry into Brazil and over 30 other global markets, contact us at [email protected] or visit https://pureglobal.com/.